Supatat Chumnumwat

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Multidrug Resistant

Pulmonary Tuberculosis

Klebsiella Pneumoniae

Top Venues

Clinical and translational science

Cardiovascular therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Palat Karnmueng, Preecha Montakantikul, Taniya Paiboonvong, Rongpong Plongla, Tanittha Chatsuwan, Supatat Chumnumwat
Mortality factors and antibiotic options in carbapenem-resistant Enterobacterales bloodstream infections: Insights from a high-prevalence setting with co-occurring NDM-1 and OXA-48. Clinical and translational science 17 (6) (2024)
Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, Pramote Tragulpiankit
Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. Clinical and translational science 17 (4) (2024)
Palat Karnmueng, Preecha Montakantikul, Taniya Paiboonvong, Rongpong Plongla, Tanittha Chatsuwan, Supatat Chumnumwat
Mortality factors and antibiotic options in carbapenem-resistant Enterobacterales bloodstream infections: Insights from a high-prevalence setting with co-occurring NDM-1 and OXA-48. Clinical and translational science 17 (6) (2024)
Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, Pramote Tragulpiankit
Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. Clinical and translational science 17 (4) (2024)
Palat Karnmueng, Preecha Montakantikul, Taniya Paiboonvong, Rongpong Plongla, Tanittha Chatsuwan, Supatat Chumnumwat
Mortality factors and antibiotic options in carbapenem-resistant Enterobacterales bloodstream infections: Insights from a high-prevalence setting with co-occurring NDM-1 and OXA-48. Clinical and translational science 17 (6) (2024)
Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, Pramote Tragulpiankit
Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. Clinical and translational science 17 (4) (2024)
Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, Pramote Tragulpiankit
Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review. Clinical and translational science 17 (4) (2024)
Warunee Mingpun, Abhasnee Sobhonslidsuk, Supatat Chumnumwat
Optimal Resting heart rate on ascites-related death in patients with Cirrhosis and Ascites using nonselective beta blockers (ORCA). Clinical and translational science (2023)
Supatat Chumnumwat, Kong Yi, Aroonrut Lucksiri, Wichit Nosoongnoen, Busba Chindavijak, Suvatna Chulavatnatol, Ajjima Sarapakdi, Surakit Nathisuwan
Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population. Cardiovascular therapeutics 36 (2) (2018)